BRPI0708095B8 - método para isolar uma fração bioativa, e, ingrediente bioativo - Google Patents
método para isolar uma fração bioativa, e, ingrediente bioativoInfo
- Publication number
- BRPI0708095B8 BRPI0708095B8 BRPI0708095A BRPI0708095A BRPI0708095B8 BR PI0708095 B8 BRPI0708095 B8 BR PI0708095B8 BR PI0708095 A BRPI0708095 A BR PI0708095A BR PI0708095 A BRPI0708095 A BR PI0708095A BR PI0708095 B8 BRPI0708095 B8 BR PI0708095B8
- Authority
- BR
- Brazil
- Prior art keywords
- bioactive
- present
- fraction
- gamma
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
ingrediente bioativo, método para isolar uma fração bioativa, e, composição bioativa. a presente invenção refere-se a ingredientes bioativos que incluem frações bioativas isoladas derivadas de suco de células de biomassa fresca de uma planta de matricária (tanacetum parthenium). as frações bioativas são ou livres de ou substancialmente livres de (gama)-lactonas (alfa)-insaturadas (por exemplo, partenolídeo). além disso, as frações bioativas tem atividade antiinflamatória e antioxidante. a presente invenção também refere-se a um método para isolar uma fração bioativa que é derivada de suco de células de biomassa fresca de uma planta de matricária (tanacetum parthenium) e que é pelo menos substancialmente livre de (gama)-lactonas (alfa)-insaturadas (por exemplo partenolídeo). a presente invenção também refere- se a um método para preparar uma fração de soro de suco de células estabilizada e uma fração de soro de suco de células concentrada estabilizada que são livres de (gama)-lactonas (gama)-insaturadas (por exemplo, partenolídeo). a presente invenção também refere-se a uma composição bioativa que inclui uma mistura de uma ou mais das frações bioativas isoladas da presente invenção.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77525706P | 2006-02-21 | 2006-02-21 | |
US60/775257 | 2006-02-21 | ||
PCT/US2007/062498 WO2007098471A2 (en) | 2006-02-21 | 2007-02-21 | Parthenolide free bioactive ingredients from feverfew (tanacetum parthenium) and processes for their production |
Publications (4)
Publication Number | Publication Date |
---|---|
BRPI0708095A2 BRPI0708095A2 (pt) | 2011-05-17 |
BRPI0708095B1 BRPI0708095B1 (pt) | 2021-03-02 |
BRPI0708095B8 true BRPI0708095B8 (pt) | 2021-03-23 |
BRPI0708095C1 BRPI0708095C1 (pt) | 2021-05-25 |
Family
ID=38438098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0708095A BRPI0708095C1 (pt) | 2006-02-21 | 2007-02-21 | método para isolar uma fração bioativa, e, ingrediente bioativo |
Country Status (10)
Country | Link |
---|---|
US (3) | US7537791B2 (pt) |
EP (1) | EP1991242B1 (pt) |
JP (4) | JP5336859B2 (pt) |
CN (1) | CN101453898B (pt) |
AU (1) | AU2007217003B2 (pt) |
BR (1) | BRPI0708095C1 (pt) |
CA (1) | CA2643255A1 (pt) |
ES (1) | ES2625848T3 (pt) |
NZ (2) | NZ607880A (pt) |
WO (1) | WO2007098471A2 (pt) |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8277852B2 (en) * | 2002-01-25 | 2012-10-02 | Akzo Nobel Surface Chemistry Llc | Bioactive botanical cosmetic compositions and processes for their production |
US8080265B2 (en) | 2009-02-20 | 2011-12-20 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating signs of skin aging |
US8075931B2 (en) * | 2009-10-02 | 2011-12-13 | Johnson & Johnson Consumer Companies, Inc. | Extracts of Phyllanthus niruri |
US8906432B2 (en) | 2009-10-02 | 2014-12-09 | Johnson & Johnson Consumer Companies, Inc. | Compositions comprising an NFκB-inhibitor and a non-retinoid collagen promoter |
US20110081305A1 (en) * | 2009-10-02 | 2011-04-07 | Steven Cochran | Compositions comprising a skin-lightening resorcinol and a skin darkening agent |
US20110081430A1 (en) | 2009-10-02 | 2011-04-07 | Simarna Kaur | COMPOSITIONS COMPRISING AN NFkB-INHIBITOR AND A TROPOELASTIN PROMOTER |
US8075930B2 (en) * | 2009-10-02 | 2011-12-13 | Johnson & Johnson Consumer Companies, Inc. | Extracts of Phyllanthus niruri |
US8916209B2 (en) * | 2009-10-02 | 2014-12-23 | Johnson & Johnson Consumer Companies, Inc. | Extracts of Phyllanthus niruri |
US8084504B2 (en) | 2009-10-02 | 2011-12-27 | Johnson & Johnson Consumer Companies, Inc. | High-clarity aqueous concentrates of 4-hexylresorcinol |
CN102573820B (zh) * | 2009-10-02 | 2015-11-25 | 强生消费者公司 | 包含抗炎共混物的组合物 |
CN107365709A (zh) | 2009-11-11 | 2017-11-21 | Isp 投资有限责任公司 | 来自应激诱导的光合生物的生物活性级分及其制备和使用方法 |
US9962326B2 (en) | 2010-08-19 | 2018-05-08 | Johnson & Johnson Consumer Inc. | Compositions comprising paulownia tomentosa wood extracts and uses thereof |
US9387349B2 (en) | 2010-08-19 | 2016-07-12 | Johnson & Johnson Consumer Inc. | Compositions comprising Paulownia tomentosa wood extracts and uses thereof |
US9168207B2 (en) | 2010-08-19 | 2015-10-27 | Johnson & Johnson Consumer Inc. | Compositions comprising Paulownia tomentosa wood extracts and uses thereof |
US9173913B2 (en) | 2010-08-19 | 2015-11-03 | Johnson & Johnson Consumer Inc. | Compositions comprising Paulownia tomentosa wood extracts and uses thereof |
CA2807690A1 (en) | 2010-08-19 | 2012-02-23 | Johnson & Johnson Consumer Companies, Inc. | Compositions comprising paulownin and/or paulownia extracts and uses thereof |
US9168219B2 (en) | 2010-08-19 | 2015-10-27 | Johnson & Johnson Consumer Inc. | Compositions comprising Paulownia tomentosa wood extracts and uses thereof |
US9168279B2 (en) | 2010-08-19 | 2015-10-27 | Johnson & Johnson Consumer Inc. | Compositions comprising paulownin and/or Paulownia extracts and uses thereof |
US9161958B2 (en) | 2010-08-19 | 2015-10-20 | Johnson & Johnson Consumer Inc. | Methods of treating cellulite |
US8895628B2 (en) | 2010-10-25 | 2014-11-25 | Johnson & Johnson Consumer Companies, Inc. | Compositions comprising a retinoid and an NFkB-inhibitor and their methods of use |
US8293293B2 (en) | 2010-12-17 | 2012-10-23 | Johnson & Johnson Consumer Companies, Inc. | Compositions comprising Lilium martagon extracts and uses thereof |
US9492492B2 (en) | 2010-12-17 | 2016-11-15 | Johnson & Johnson Consumer Inc. | Compositions comprising Lilium martagon extracts and uses thereof |
US8486466B2 (en) | 2010-12-17 | 2013-07-16 | Johnson & Johnson Consumer Companies, Inc. | Compositions comprising Lilium siberia extracts and uses thereof |
EP2465518B1 (en) | 2010-12-17 | 2016-03-02 | Johnson & Johnson Consumer Companies Inc. | Compositions Comprising Lilium Candidum Extracts and Uses Thereof |
EP2465489B1 (en) | 2010-12-17 | 2018-08-22 | Johnson & Johnson Consumer Inc. | Compositions comprising lilium martagon extracts and uses thereof |
EP2465490A3 (en) | 2010-12-17 | 2015-06-17 | Johnson & Johnson Consumer Companies Inc. | Compositions comprising Lilium Siberia extracts and uses thereof |
US9421236B2 (en) | 2010-12-17 | 2016-08-23 | Johnson & Johnson Consumer Inc. | Compositions comprising Lilium siberia extracts and uses thereof |
US8481093B2 (en) * | 2010-12-17 | 2013-07-09 | Johnson & Johnson Consumer Companies, Inc. | Compositions comprising Lilium candidum extracts and uses thereof |
EP2794011B1 (en) | 2011-12-22 | 2016-12-14 | The Procter and Gamble Company | Compositions and methods for improving the appearance of aging hair |
KR20140107325A (ko) | 2011-12-22 | 2014-09-04 | 아크조 노벨 케미칼즈 인터내셔널 비.브이. | 피부 항노화 활성을 가진 생활성 조성물 |
JP5860166B2 (ja) | 2011-12-22 | 2016-02-16 | ザ プロクター アンド ギャンブルカンパニー | 皮膚の処置のための組成物及び方法 |
ES2674593T3 (es) * | 2011-12-22 | 2018-07-02 | Isp Investments Llc | Composiciones bioactivas para el cabello de acción anti-edad |
US9814659B2 (en) | 2012-04-02 | 2017-11-14 | Johnson & Johnson Consumer Inc. | Methods of lightening the skin |
US20140086859A1 (en) | 2012-09-24 | 2014-03-27 | Johnson & Johnson Consumer Companies, Inc. | Low oil compositions comprising a 4-substituted resorcinol and a high carbon chain ester |
KR20150083996A (ko) | 2012-11-14 | 2015-07-21 | 아크조 노벨 케미칼즈 인터내셔널 비.브이. | 생활성 식물 조성물의 제조 방법, 및 상기 방법으로 제조되는 조성물 |
EP2969024A1 (en) * | 2013-03-13 | 2016-01-20 | ISP Investments Inc. | Bioactive botanical compositions and uses thereof |
US9579278B2 (en) | 2013-05-10 | 2017-02-28 | Johnson & Johnson Consumer Inc. | Compositions comprising extracts of Bursera simaruba |
US10123966B2 (en) | 2013-05-16 | 2018-11-13 | The Procter And Gamble Company | Hair thickening compositions and methods of use |
EP2829303A1 (en) | 2013-07-22 | 2015-01-28 | Johnson & Johnson Consumer Companies Inc. | Compositions comprising extract of malva neglecta and method of treating a skin condition with malva neglecta |
US9522168B2 (en) | 2014-05-29 | 2016-12-20 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Acmella oleracea extracts and uses thereof |
RU2601813C1 (ru) * | 2015-04-22 | 2016-11-10 | Ильзира Ильсуровна Гибадулина | Способ мацерации тканей листа липы мелколистной tilia cordata mill |
CN106691902B (zh) | 2015-08-14 | 2021-04-20 | 强生消费者公司 | 包含显齿蛇葡萄和合欢提取物的组合物和使用方法 |
US10660846B2 (en) | 2015-09-29 | 2020-05-26 | Johnson & Johnson Consumer Inc. | Method and composition for lightening skin using a cell culture extract |
US20170128357A1 (en) | 2015-11-06 | 2017-05-11 | Johnson & Johnson Consumer Inc. | Topical gel cream composition |
US10172787B2 (en) | 2015-12-08 | 2019-01-08 | The Procter & Gamble Company | Method of regulating a condition of mammalian keratinous tissue |
US10182981B2 (en) | 2015-12-08 | 2019-01-22 | The Procter & Gamble Company | Method of regulating a skin condition |
US10335363B2 (en) | 2015-12-08 | 2019-07-02 | The Procter & Gamble Company | Skin care composition and method of making the same |
US10537515B2 (en) | 2015-12-08 | 2020-01-21 | The Procter & Gamble Company | Personal care composition and method of making the same |
US20170172913A1 (en) | 2015-12-17 | 2017-06-22 | Johnson & Johnson Consumer Inc. | Topical Compositions Comprising Pichia Anomala and Chicory Root Extracts |
CN105561321B (zh) * | 2015-12-28 | 2019-04-12 | 陕西嘉禾生物科技股份有限公司 | 一种小白菊内酯的稳定方法 |
WO2017147578A1 (en) | 2016-02-25 | 2017-08-31 | Isp Investments Llc | Mitigating adverse effects of sunlight with ingredients obtained from living plants |
CN105815326B (zh) * | 2016-03-11 | 2020-10-16 | 江苏省中国科学院植物研究所 | 含小白菊内酯的农用杀菌剂制备方法及其用途 |
WO2018048892A1 (en) | 2016-09-07 | 2018-03-15 | Isp Investments Llc | Method for increasing lipolysis using a composition comprising bioactive nelumbo nucifera (lotus) extract |
US10543240B2 (en) | 2016-12-12 | 2020-01-28 | Johnson & Johnson Consumer Inc. | Topical composition containing glycerin and yeast extract |
US10206870B2 (en) | 2016-12-12 | 2019-02-19 | Johnson & Johnson Consumer Inc. | Topical composition containing glycerin and yeast extract |
WO2020021481A1 (en) | 2018-07-27 | 2020-01-30 | Johnson & Johnson Vision Care, Inc. | Compositions and methods for treating the eye |
CA3106898A1 (en) | 2018-07-27 | 2020-01-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
US20200030226A1 (en) | 2018-07-27 | 2020-01-30 | Johnson & Johnson Consumer Inc. | Botanical and bacterial extracts displaying retinol-like activity |
CN112888450A (zh) | 2018-07-27 | 2021-06-01 | 强生外科视力公司 | 用于治疗眼睛的组合物和方法 |
US11197841B2 (en) | 2019-07-23 | 2021-12-14 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
US10966948B2 (en) | 2019-07-23 | 2021-04-06 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
BR112021000724A2 (pt) | 2018-07-27 | 2021-04-13 | Johnson & Johnson Surgical Vision, Inc. | Composições e métodos para tratar os olhos |
US11166997B2 (en) | 2018-07-27 | 2021-11-09 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
AU2019203692A1 (en) | 2018-08-30 | 2020-03-19 | Johnson & Johnson Consumer Inc. | Topical composition containing glycerin and yeast extract |
US20200069562A1 (en) | 2018-08-30 | 2020-03-05 | Johnson & Johnson Consumer Inc. | Topical compositions comprising pichia anomala and a soy product |
US11110051B2 (en) | 2018-08-30 | 2021-09-07 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Pichia anomala and n-acetyl glucosamine |
US11045416B2 (en) | 2018-08-30 | 2021-06-29 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Pichia anomala and retinol |
BR112021011103A8 (pt) | 2018-12-18 | 2022-08-09 | Currahee Holding Company Inc | Emplastro personalizado para aplicação tópica |
CN112823789B (zh) | 2019-11-19 | 2024-05-10 | 强生外科视力公司 | 用于治疗眼睛的组合物和方法 |
US11969454B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
US11969451B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
US20210299203A1 (en) | 2020-03-26 | 2021-09-30 | Johnson & Johnson Consumer Inc. | Compositions comprising carum carvi and rosmarinus officinalis extracts and methods of using same |
WO2021191815A1 (en) | 2020-03-26 | 2021-09-30 | Johnson & Johnson Consumer Inc. | Compositions comprising carum carvi and rosmarinus officinalis extracts and methods of using same |
EP4059508A1 (en) | 2021-03-19 | 2022-09-21 | Johnson & Johnson Consumer Inc. | Methods of using compositions comprising an iceland moss extract |
EP4170315A1 (en) | 2021-10-22 | 2023-04-26 | Johnson & Johnson Consumer Inc. | Methods of evaluating micro rna |
EP4252860A1 (en) | 2022-03-31 | 2023-10-04 | Johnson & Johnson Consumer Inc. | Anhydrous formulations suitable as lip balms |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1312342B1 (it) * | 1999-06-03 | 2002-04-15 | Indena Spa | Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi. |
BRPI0006634B8 (pt) * | 1999-06-03 | 2021-05-25 | Johnson & Johnson Consumer Fr | composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios |
US20030003170A1 (en) | 2000-06-02 | 2003-01-02 | Theresa Callaghan | Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) |
GB9913408D0 (en) | 1999-06-10 | 1999-08-11 | Albright & Wilson Uk Ltd | Personal care formulations |
US7074747B1 (en) | 1999-07-01 | 2006-07-11 | Johnson & Johnson Consumer Companies, Inc. | Cleansing compositions |
WO2001001949A1 (en) | 1999-07-01 | 2001-01-11 | Johnson And Johnson Consumer Companies, Inc. | Cleansing compositions |
US20050009717A1 (en) | 1999-07-01 | 2005-01-13 | Lukenbach Elvin R. | Foaming make-up removing cleansing compositions |
US6762158B2 (en) | 1999-07-01 | 2004-07-13 | Johnson & Johnson Consumer Companies, Inc. | Personal care compositions comprising liquid ester mixtures |
US6908630B2 (en) * | 2000-08-01 | 2005-06-21 | Metaproteomics, Llc | Combinations of sesquiterpene lactones and ditepene triepoxide lactones for synergistic inhibition of cyclooxygenase-2 |
EP1367993B1 (en) | 2001-03-16 | 2007-05-16 | Johnson & Johnson Consumer Companies, Inc. | Use of a feverfew extract for regulating skin ageing factors |
US20030077343A1 (en) | 2001-03-16 | 2003-04-24 | Martin Katharine M. | Composition containing feverfew extract and use thereof |
US7442391B2 (en) | 2002-01-25 | 2008-10-28 | Integrated Botanical Technologies, Llc | Bioactive botanical cosmetic compositions and processes for their production |
US20050142093A1 (en) | 2003-12-24 | 2005-06-30 | Gregory Skover | Treatment of skin with an apparatus and a benefit agent |
ES2465949T3 (es) * | 2004-01-12 | 2014-06-09 | Akzo Nobel Surface Chemistry Llc | Composiciones bioactivas de plantas de Theacea y procedimientos para su producción y uso |
US20070086972A1 (en) | 2005-09-12 | 2007-04-19 | Jacob Birnbaum | Hair growth compositions and methods for treating hair loss or related conditions |
CN103025862B (zh) * | 2010-05-04 | 2015-02-11 | 韩国生命工学研究院 | 新型破囊壶菌类微藻及用其生产生物油的方法 |
-
2007
- 2007-02-21 NZ NZ607880A patent/NZ607880A/en not_active IP Right Cessation
- 2007-02-21 EP EP07757276.6A patent/EP1991242B1/en active Active
- 2007-02-21 US US11/677,435 patent/US7537791B2/en active Active
- 2007-02-21 NZ NZ595600A patent/NZ595600A/xx not_active IP Right Cessation
- 2007-02-21 CN CN200780013469.7A patent/CN101453898B/zh active Active
- 2007-02-21 BR BRPI0708095A patent/BRPI0708095C1/pt active IP Right Grant
- 2007-02-21 ES ES07757276.6T patent/ES2625848T3/es active Active
- 2007-02-21 JP JP2008556525A patent/JP5336859B2/ja not_active Expired - Fee Related
- 2007-02-21 AU AU2007217003A patent/AU2007217003B2/en not_active Ceased
- 2007-02-21 WO PCT/US2007/062498 patent/WO2007098471A2/en active Application Filing
- 2007-02-21 CA CA002643255A patent/CA2643255A1/en not_active Abandoned
-
2009
- 2009-03-26 US US12/412,126 patent/US8728548B2/en not_active Ceased
-
2013
- 2013-04-04 JP JP2013078229A patent/JP2013151544A/ja active Pending
-
2015
- 2015-06-26 JP JP2015128677A patent/JP6141912B2/ja active Active
-
2016
- 2016-05-20 US US15/161,134 patent/USRE46788E1/en active Active
- 2016-10-21 JP JP2016206859A patent/JP2017061476A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
USRE46788E1 (en) | 2018-04-17 |
AU2007217003B2 (en) | 2013-04-04 |
CN101453898A (zh) | 2009-06-10 |
ES2625848T3 (es) | 2017-07-20 |
NZ607880A (en) | 2014-11-28 |
JP6141912B2 (ja) | 2017-06-07 |
CA2643255A1 (en) | 2007-08-30 |
EP1991242A4 (en) | 2010-11-03 |
BRPI0708095C1 (pt) | 2021-05-25 |
US8728548B2 (en) | 2014-05-20 |
JP2009527582A (ja) | 2009-07-30 |
JP2017061476A (ja) | 2017-03-30 |
JP2015205906A (ja) | 2015-11-19 |
JP2013151544A (ja) | 2013-08-08 |
BRPI0708095B1 (pt) | 2021-03-02 |
CN101453898B (zh) | 2014-03-26 |
US20090186109A1 (en) | 2009-07-23 |
NZ595600A (en) | 2013-03-28 |
EP1991242A2 (en) | 2008-11-19 |
US20070196523A1 (en) | 2007-08-23 |
JP5336859B2 (ja) | 2013-11-06 |
WO2007098471A2 (en) | 2007-08-30 |
WO2007098471A3 (en) | 2008-11-20 |
BRPI0708095A2 (pt) | 2011-05-17 |
EP1991242B1 (en) | 2017-04-26 |
US7537791B2 (en) | 2009-05-26 |
AU2007217003A1 (en) | 2007-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0708095B8 (pt) | método para isolar uma fração bioativa, e, ingrediente bioativo | |
Odiatou et al. | Identification of the factors responsible for the in vitro pro-oxidant and cytotoxic activities of the olive polyphenols oleuropein and hydroxytyrosol | |
Gouranton et al. | Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue | |
BR112022024943A2 (pt) | Composição oral efervescente compreendendo um ingrediente ativo | |
Qin et al. | Icariin stimulates the proliferation of rat bone mesenchymal stem cells via ERK and p38 MAPK signaling | |
Wang et al. | Cordycepin prevents oxidative stress-induced inhibition of osteogenesis | |
EP4360651A3 (en) | Glp-1 compositions and uses thereof | |
BR112017025339A2 (pt) | composições nutricionais contendo um nível elevado de inositol e usos das mesmas | |
MY158675A (en) | Fat-reduced soybean protein material and soybean emulsion composition, and processes for production thereof | |
Subramanya et al. | Total polyphenolic contents and in vitro antioxidant properties of eight Sida species from Western Ghats, India | |
BR112019005652A2 (pt) | método de isolamento de células-tronco mesenquimais da membrana amniótica do cordão umbilical utilizando um meio de cultura de células | |
BR112018069876A2 (pt) | composição cosmética, método para fotoestabilização de resveratrol, polidatina, ou uma mistura dos mesmos com baicalina e método | |
BR112022002953A2 (pt) | Composições e métodos para condicionamento não tóxico | |
WO2009130005A3 (en) | Preparation and use of a plant extract from solanum glaucophyllum with an enriched content of 1,25-dihydroxyvitamin d3 glycosides and quercetin glycosides | |
BRPI0916936B8 (pt) | composições farmacêuticas, uso de clevidipina e método de reduzir impurezas. | |
BR112013026965A2 (pt) | método para inibir micro-organismos prejudiciais e composição formadora de barreira para os mesmos | |
BR112018016307A2 (pt) | usos de composição e de produto, método de combate a maus odores e composição | |
BR112019024641A2 (pt) | Composições de óleo contendo éster alquílico intensificado e métodos de fabricação e utilização das mesmas | |
Wang et al. | Quercetin reversed lipopolysaccharide-induced inhibition of osteoblast differentiation through the mitogen‑activated protein kinase pathway in MC3T3-E1 cells | |
BR0309993A (pt) | Método para reduzir a produção de metano que emana das atividades digestivas de um animal, composição para alimentação, pré-mistura de alimentação, e, suplemento para água de beber | |
BR112018004717A2 (pt) | ?composição? | |
AR053691A1 (es) | Agentes endoparasiticidas | |
TR201818784T4 (tr) | Selenyum İle Kombinasyon Halinde Aronia Sp.'nin Bir Ekstraktını İçeren Bağışık Uyarıcı Terkip | |
BR112021021557A2 (pt) | Corpos de cetona confinados em microesferas | |
BR112014027301A2 (pt) | composição que compreende um ingrediente sensível |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: AKZO NOBEL SURFACE CHEMISTRY LLC (US) |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/03/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REF. RPI 2617 DE 02/03/2021 QUANTO AO QUADRO REIVINDICATORIO. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/02/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B15V | Prolongation of time limit allowed |